3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
4
Biliary Tract Neoplasms
2
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
Malignant Neoplasms of Digestive Organs
1
Klatskin Tumor
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Epstein-Barr Virus Infections
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bile Duct Neoplasms
1
Advanced Biliary Tract Carcinoma
1
Interventions
Injections
6
pembrolizumab
5
toripalimab
3
tislelizumab
3
senaparib
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Tegafur
×
1 year
×
Clear all
No trials found.